Bench in a Box Technologies

Bench in a Box Technologies is developing a diagnostic platform designed to provide rapid, portable molecular testing for field and low-resource environments. Its core innovation is a patent-pending Protein Signal Amplification (PSA) platform, which enables specific molecular detection without the need for electricity, refrigeration, or complex laboratory infrastructure. The process uses specialized probes and a capture interface to immobilize targets, followed by a universal reporter solution that produces a distinct color change in under five minutes. By eliminating the requirement for traditional PCR/qPCR thermocycling, the technology offers a flexible approach to detection that can incorporate various molecules, such as antibodies, as a targeting mechanism.

This platform is intended to democratize access to high-quality diagnostics across diverse sectors, including clinical healthcare, veterinary medicine, and environmental monitoring. By focusing on point-of-care solutions, the company aims to overcome the logistical barriers often associated with diagnostic testing in remote or rural areas. The organization is currently led by a team with expertise in molecular diagnostics, pharmaceutical R&D, and scientific logistics, and it is actively pursuing investment to scale its development and commercialization efforts. Bench in a Box Technologies is based in Bay City, Michigan.